China National Medicines Corporation Ltd. (600511.SS)
CNY 34.43
(1.89%)
CNY 34.43
(1.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 49.69 Billion | 45.49 Billion | 46.46 Billion | 40.37 Billion | 44.64 Billion | 38.73 Billion |
| Cost of Revenue | 45.84 Billion | 41.67 Billion | 42.83 Billion | 37.23 Billion | 40.73 Billion | 35.32 Billion |
| Gross Profit | 3.85 Billion | 3.82 Billion | 3.63 Billion | 3.14 Billion | 3.9 Billion | 3.41 Billion |
| Operating Expenses | 1.04 Billion | 1.42 Billion | 1.43 Billion | 1.43 Billion | 1.55 Billion | 1.5 Billion |
| Selling, General and Administrative Expenses | 593.98 Million | 1.01 Billion | 997.06 Million | 1.07 Billion | 1.1 Billion | 1.1 Billion |
| Research and Development Expenses | 71.19 Million | 66.99 Million | 55.75 Million | 51.87 Million | 44.92 Million | 30.44 Million |
| Other Expenses | - | 343.45 Million | 382.03 Million | 309.78 Million | 404.62 Million | -15.24 Million |
| Cost and Expenses | 46.75 Billion | 43.09 Billion | 44.27 Billion | 38.67 Billion | 42.29 Billion | 36.82 Billion |
| Operating Income | 2.94 Billion | 2.69 Billion | 2.44 Billion | 1.91 Billion | 2.43 Billion | 2.03 Billion |
| Interest Expense | 44.84 Million | 26.87 Million | 43.71 Million | 56.8 Million | 48.45 Million | 175.05 Million |
| Income Tax Expense | 596.41 Million | 559.18 Million | 516.3 Million | 408.09 Million | 546.08 Million | 430.55 Million |
| Earnings before Tax | 2.93 Billion | 2.68 Billion | 2.44 Billion | 1.91 Billion | 2.42 Billion | 2.02 Billion |
| Net Income | 2.14 Billion | 1.96 Billion | 1.75 Billion | 1.38 Billion | 1.6 Billion | 1.4 Billion |
| Earnings Per Share Basic | 2.84 | 2.60 | 2.32 | 1.83 | 2.11 | 1.83 |
| Earnings Per Share Diluted | 2.84 | 2.60 | 2.32 | 1.83 | 2.11 | 1.83 |
| Weighted Average Shares Outstanding | 754.5 Million | 754.5 Million | 754.5 Million | 754.5 Million | 761.94 Million | 766.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 754.5 Million | 754.5 Million | 754.5 Million | 754.5 Million | 761.94 Million | 766.72 Million |
| Gross Margin | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| EBIT Margin | 0.06 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 |
| Profit Margin | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 |
| EBITDA | 2.82 Billion | 2.9 Billion | 2.66 Billion | 2.14 Billion | 2.6 Billion | 2.03 Billion |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 13.27 Billion | 12.6 Billion | 12.12 Billion | 49.58 Billion | 13.13 Billion | 12.38 Billion |
| Cost of Revenue | 12.35 Billion | 11.77 Billion | 11.27 Billion | 45.84 Billion | 12.03 Billion | 11.42 Billion |
| Gross Profit | 915.67 Million | 830.39 Million | 852.08 Million | 3.73 Billion | 1.09 Billion | 961.55 Million |
| Operating Expenses | 346.96 Million | 276.36 Million | 339.09 Million | 1.37 Billion | 360.99 Million | 360.21 Million |
| Selling, General and Administrative Expenses | 637.52 Million | 265.94 Million | 301.98 Million | - | 369.31 Million | 488.75 Million |
| Research and Development Expenses | 15.34 Million | 9.15 Million | 13.94 Million | - | 13.62 Million | 18.83 Million |
| Other Expenses | -305.9 Million | -1.25 Million | -262.35 Thousand | -13.46 Million | 21.94 Million | -9.24 Million |
| Cost and Expenses | 12.7 Billion | 12.04 Billion | 11.6 Billion | 47.21 Billion | 12.39 Billion | 11.78 Billion |
| Operating Income | 659.65 Million | 554.02 Million | 613.79 Million | 2.36 Billion | 733.35 Million | 670.79 Million |
| Interest Expense | 8.7 Million | 8.24 Million | 7.31 Million | 142.98 Million | -3.58 Million | 9.36 Million |
| Income Tax Expense | 136.74 Million | 135.74 Million | 118.41 Million | 596.41 Million | 192.27 Million | 142.31 Million |
| Earnings before Tax | 647.99 Million | 563.23 Million | 613.53 Million | 2.47 Billion | 817.48 Million | 661.54 Million |
| Net Income | 480.76 Million | 541.05 Million | 459.45 Million | 2.14 Billion | 683.7 Million | 477.71 Million |
| Earnings Per Share Basic | 0.64 | 0.72 | 0.61 | - | 0.91 | 0.63 |
| Earnings Per Share Diluted | 0.64 | 0.72 | 0.61 | - | 0.91 | 0.63 |
| Weighted Average Shares Outstanding | 754.5 Million | 754.5 Million | 754.56 Million | 754.5 Million | 754.5 Million | 754.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 754.5 Million | 754.5 Million | 754.56 Million | 754.5 Million | 754.5 Million | 754.5 Million |
| Gross Margin | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 |
| EBIT Margin | 0.05 | 0.05 | 0.05 | - | 0.06 | 0.06 |
| Profit Margin | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 |
| EBITDA | 656.7 Million | 616.7 Million | 655.18 Million | - | 786.1 Million | 710.4 Million |
| Earnings Before Tax Margin | 0.05 | 0.04 | 0.05 | 0.05 | 0.06 | 0.05 |
6730
IGEN
UMS
9127
GWA
LFST